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Summary
Background: Several checkpoint pathways employ
Wee1-mediated inhibitory tyrosine phosphorylation of
cyclin-dependent kinases (CDKs) to restrain cell-cycle
progression. Whereas in vertebrates this strategy can
delay both DNA replication and mitosis, in yeast cells
only mitosis is delayed. This is particularly surprising be-
cause yeasts, unlike vertebrates, employ a single family
of cyclins (B type) and the same CDK to promote both S
phase and mitosis. The G2-specific arrest could be ex-
plained in two fundamentally different ways: tyrosine
phosphorylation of cyclin/CDK complexes could leave
sufficient residual activity to promote S phase, or S
phase-promoting cyclin/CDK complexes could some-
how be protected from checkpoint-induced tyrosine
phosphorylation.
Results: We demonstrate that in Saccharomyces cere-
visiae, several cyclin/CDK complexes are protected
from inhibitory tyrosine phosphorylation, allowing
Clb5,6p to promote DNA replication and Clb3,4p to pro-
mote spindle assembly, even under checkpoint-induc-
ing conditions that block nuclear division. In vivo, S
phase-promoting Clb5p/Cdc28p complexes were phos-
phorylated more slowly and dephosphorylated more
effectively than were mitosis-promoting Clb2p/Cdc28p
complexes. Moreover, we show that the CDK inhibitor
(CKI) Sic1p protects bound Clb5p/Cdc28p complexes
from tyrosine phosphorylation, allowing the accumula-
tion of unphosphorylated complexes that are unleashed
when Sic1p is degraded to promote S phase. The verte-
brate CKI p27Kip1 similarly protects Cyclin A/Cdk2
complexes from Wee1, suggesting that the antagonism
between CKIs and Wee1 is evolutionarily conserved.
Conclusions: In yeast cells, the combination of CKI
binding and preferential phosphorylation/dephosphory-
lation of different B cyclin/CDK complexes renders S
phase progression immune from checkpoints acting
via CDK tyrosine phosphorylation.
Introduction
The execution of cell-cycle events is driven by cyclin-
dependent kinases (CDKs) in association with regulatory
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of North Carolina, Chapel Hill, NC 27599.CURBIcyclin subunits [1]. Cyclin/CDK activity is regulated by
stoichiometric binding of CDK inhibitors (CKIs), as well
as inhibitory tyrosine phosphorylation by the Wee1 fam-
ily of kinases and dephosphorylation by the Cdc25 fam-
ily of phosphatases [1]. The balance between Wee1 and
Cdc25 activities is controlled by cell-cycle checkpoint
pathways, thereby linking cell-cycle progression to
successful completion of key events [2–4].
In vertebrates, Wee1 can delay both DNA replication
and mitosis when cells experience DNA damage. Phos-
phorylation of Cyclin E/Cdk2 complexes inhibits DNA
replication, whereas phosphorylation of Cyclin B/Cdk1
complexes inhibits mitotic entry [5–9], suggesting that
Wee1 has broad specificity for divergent complexes. In
yeasts, both S phase and nuclear division are triggered
by B cyclins associated with a single CDK [1], yet check-
points acting through inhibitory CDK phosphorylation
appear to arrest the cell cycle exclusively in G2
[10–12]. This surprising difference from vertebrates
suggests that yeasts are more selective in how they de-
ploy Wee1.
In the budding yeast S. cerevisiae, the CDK Cdc28p
can be activated by six B cyclins, Clb1–6p. Although
these cyclins display a significant degree of redun-
dancy, they are expressed and act at different times in
the cell cycle, with Clb5,6p primarily triggering S phase
and Clb1,2p primarily triggering nuclear division [13].
A single Wee1-family protein, Swe1p, and a single
Cdc25-family protein, Mih1p, control Cdc28p phosphor-
ylation at tyrosine 19 (Y19) [11, 14]. They act in the
morphogenesis checkpoint to block nuclear division
(but not DNA replication) in response to perturbations
of the cytoskeleton or bud formation [12, 15].
To address why Swe1p affects mitosis but not S
phase, we have evaluated the degree to which different
cyclin/Cdc28p complexes undergo tyrosine phosphory-
lation under various circumstances. Our results indicate
that S and M phase-promoting cyclin/Cdc28p com-
plexes are differentially regulated by Swe1p and Mih1p
and that binding of the CKI Sic1p protects Clb5p/
Cdc28p complexes from inhibitory phosphorylation.
Results
Actin Depolymerization Blocks Nuclear Division
but Not DNA Replication or Spindle Formation
Stresses, mutations, and drugs that delay bud emer-
gence also delay nuclear division in a Swe1p-dependent
manner (reviewed in [4]). The duration of the delay
depends on the specific stimulus, and the strongest
documented response is a prolonged arrest after treat-
ment with the actin-depolymerizing drug latrunculin
(LAT) [15]. Although the arrest of nuclear division is
well documented, there has not been a detailed analysis
of the timing of earlier cell-cycle events in response to
this stress. In cells synchronized by pheromone arrest
and release, LAT treatment blocked both bud emer-
gence and nuclear division (Figure 1A) but had no effectO 5706
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1182Figure 1. Effect of Actin Depolymerization on DNA Replication, Spindle Assembly, and Nuclear Division
Cells were synchronized by pheromone arrest/release and part of the culture was treated with 150 mM LAT at 21 min after release from G1 arrest
(just prior to budding).
(A) WT (DLY7974) cells were scored for budding (circles) and nuclear division (squares) (n > 200 cells). The block of nuclear division was largely
Swe1p dependent (Figure S1A).
(B) LAT did not influence the timing of S phase, either in the presence or absence (Figure S1B) of Swe1p as assessed by FACS analysis.
(C) Spindle formation was monitored by fluorescence microscopy to visualize the SPB marker Spc42-GFP (n > 200 cells). The small delay
induced by LAT was largely Swe1p dependent (Figure S1C).
(D) Roles of different B cyclin/Cdc28p complexes in the yeast cell cycle [18, 19, 21].
(E) clb5D clb6D (DLY8300) and clb5D clb6D swe1D (DLY8963) cells were synchronized and DNA replication was monitored by flow cytometry (see
Figures S1D and S1E for synchrony data). Overlays of untreated (black) and LAT-treated (red) FACS profiles 90 min after release from G1 arrest.
For comparison, WT FACS profiles during (30 min) and after (40 min) S phase are shown to illustrate lack of LAT effect in those cells (from data
in [B]).
(F) WT (DLY7974) and clb3D clb4D (DLY8297) cells were synchronized and spindle formation was monitored as above (see Figure S1G for
synchrony data). Left, representative fluorescence and DIC images from clb3D clb4D cells. Right, >200 cells were scored for SPB separation
at 60 min.CURBIO 5706
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only a small (though reproducible) delay in spindle as-
sembly (Figure 1C). The inability of LAT to block DNA
replication was observed even in cells synchronized by
centrifugal elutriation, in which a longer G1 leaves >30
min between LAT addition and S phase (Figure S2 in
the Supplemental Data available online). Thus, DNA rep-
lication is completely unaffected, and spindle assembly
is only slightly affected, in response to the strongest
available checkpoint stimulus.
Specific Cdc28pComplexes Trigger DNAReplication
and Spindle Assembly in LAT-Treated Cells
The six B cyclins in S. cerevisiae can be subdivided into
three highly related pairs [13]. Clb5,6p are expressed in
late G1 and trigger DNA replication [17, 18], Clb3,4p are
expressed in S and G2/M [19, 20] and are thought to
trigger spindle assembly, and Clb1,2p are expressed
in G2/M and are required for nuclear division [20, 21]
(Figure 1D). Clb1,2p can also trigger DNA replication
and spindle assembly when either of the other cyclin
pairs are absent, albeit after a delay (Figure 1D and Fig-
ures S1E and S1G; note that this implies that Clb5,6p are
normally rate limiting for DNA replication and Clb3,4p
are normally rate limiting for spindle assembly). How-
ever, we found that clb5D clb6D cells treated with LAT
failed to replicate their DNA by 90 min (Figure 1E),
although some replication occurred by 120 min
(Figure S1F); this replication delay was Swe1p depen-
dent (Figure 1E). In addition, clb3D clb4D cells treated
with LAT failed to separate their SPBs (Figure 1F).
Thus, Clb5,6p complexes remain able to promote DNA
replication, and Clb3,4p complexes remain able to pro-
mote spindle assembly after LAT treatment. The Clb1,2p
complexes, which can normally compensate for loss of
these cyclins, can no longer do so (or do so only after
a prolonged delay) under these checkpoint-inducing
conditions.
Selective Phosphorylation of Clb/Cdc28p
Complexes
Our findings suggest that the specific block of nuclear
division in response to LAT reflects selective inhibition
of Clb1,2p/Cdc28p while Clb3–6p/Cdc28p remain ac-
tive. In the simplest scenario, selective inhibition could
be due to selective phosphorylation by Swe1p. Previous
work showed that Swe1p could phosphorylate Clb2p/
Cdc28p but not Cln2p/Cdc28p complexes in vitro, pro-
viding a precedent for cyclin specificity [11]. However,
Cln2p is a highly diverged G1 cyclin that is only distantly
related to Clb1–6p [22]. To assess the phosphorylation
state of Cdc28p associated with the more closely
related Clb1–6p cyclins, we used TAP-tagged cyclins
expressed from their endogenous promoters. Specific
cyclin/Cdc28p complexes were isolated from lysates
of asynchronous cultures, and the relative level of phos-
phorylation on the associated Cdc28p was evaluated by
western blot. Because of their low abundance, Cln3p,
Clb1p, and Clb6p were omitted from the analysis. Indi-
vidual blots were probed simultaneously with primary
antibodies recognizing phospho-Y19-Cdc28p (pY19) or
total Cdc28p (PSTAIRE), followed by fluorescently la-
beled secondary antibodies. No phosphorylation was
detected in cells lacking Swe1p, confirming that theCURBIOpY19 signal is specific for Swe1p-catalyzed Cdc28p
phosphorylation (Figure 2A). The ratio of pY19-to-
PSTAIRE measured with a fluorescent scanner dis-
played a linear relation to the input phosphorylation
ratio, validating the assay (Figure 2B).
In wild-type cells, there was a low basal level of
Cdc28p Y19 phosphorylation (Figure 2A), which was de-
tectable only on Clb2p complexes (Figure 2C). Thus,
phosphorylation is indeed selective for Clb2p/Cdc28p
under unperturbed conditions. Because of the large
number of cells required for this assay, assessing cyclin-
associated Cdc28p phosphorylation after LAT treat-
ment was not economically feasible. However, we could
mimic partial checkpoint activation by deleting HSL1,
a negative regulator of Swe1p [23]. Hsl1p-mediated
Swe1p degradation is blocked by stresses that block
bud emergence [24, 25], and hsl1D mutants exhibit ele-
vated levels of Cdc28p Y19 phosphorylation (Figure 2A).
Nevertheless, these cells also showed selective phos-
phorylation of Clb2p/Cdc28p (Figure 2D). A lower
degree of phosphorylation was detected on Clb3,4p
complexes, whereas no appreciable phosphorylation
was detected on Clb5p or Cln1,2p complexes.
The cyclin-selective phosphorylation we observed
could be due to a preference of Swe1p for Clb2p com-
plexes, or a preference of Mih1p for other complexes,
or both. To assess the contribution of Mih1p, we exam-
ined Cdc28p phosphorylation in mih1D cells (Figure 2E).
Strikingly, these cells exhibited comparable levels of
Y19 phosphorylation in Clb5p and Clb2p complexes,
indicating that Clb5p/Cdc28p is normally maintained in
an unphosphorylated state by Mih1p. There was also
significant phosphorylation of Clb3,4p complexes in
mih1D cells, though reproducibly at somewhat lower
levels than those of Clb2p and Clb5p complexes. In ag-
gregate, these data indicate that the Swe1p/Mih1p sys-
tem is ‘‘tuned’’ to selectively promote phosphorylation
of Clb2p-associated Cdc28p in vivo, providing an expla-
nation for why LAT blocks nuclear division but not DNA
replication or spindle assembly.
LAT Treatment of mih1D Cells Does Not Block
DNA Replication
As Cdc28p associated with Clb5p became phosphory-
lated at a stoichiometry comparable to that of Cdc28p
associated with Clb2p in mih1D cells (Figure 2E), we ex-
pected that LAT treatment of mih1D cells would inhibit
DNA replication. However, LAT treatment had abso-
lutely no effect on the timing of DNA replication in
mih1D cells (Figure 3). Similar results were obtained
with mih1D cells synchronized by centrifugal elutriation
(Figure S2). Thus, even without the protection conferred
by Mih1p, Clb5p complexes retain the ability to promote
DNA replication after actin stress.
Clb5p/Cdc28p Kinase Activity Is Inhibited by Cdc28p
Y19 Phosphorylation
Why does Clb5p-induced DNA replication proceed un-
impeded (Figure 3) despite the Y19 phosphorylation of
Clb5p-associated Cdc28p (Figure 2) in mih1D cells?
The simplest way to explain this observation would be
that in contrast to Clb2p/Cdc28p, Clb5p/Cdc28p
activity is not inhibited by Y19 phosphorylation. To test
this possibility, we compared the kinase activities of5706
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1184Figure 2. Selective Phosphorylation of B Cyclin/Cdc28p Complexes
(A) Y19 phosphorylation of the complete cellular pool of Cdc28p from WT (DLY7598), swe1D (DLY7712),hsl1D (DLY7944),mih1D (DLY7854),mih1D
hsl7-OFF (DLY8197), and GAL1-SWE1 (DLY7946) strains. The first four strains were harvested during exponential growth, and the other strains
were arrested by addition of dextrose (lane 5) or galactose (lane 6) as described in the Supplemental Experimental Procedures. The graph shows
the ratio of phosphorylated (pY19)-to-total Cdc28p (PSTAIRE) for each strain, normalized to the level inmih1D hsl7-OFF arrested cells (this is the
maximal experimentally obtained phosphorylation, but does not represent 100% phosphorylated Cdc28p because only B cyclin-bound Cdc28p is
phosphorylated). Note that the PSTAIRE antibody recognizes Pho85p (upper band) as well as Cdc28p (lower band) in whole-cell lysates.
(B) Linearity of the Cdc28p phosphorylation measurement. Lysate from swe1D cells (DLY7712), lacking Cdc28p Y19 phosphorylation, was mixed
with an increasing proportion of lysate from arrested mih1D hsl7-OFF cells (DLY8197), in which Cdc28p is maximally phosphorylated (the total
amount of protein was equal in each lane). The ratio of pY19-to-total Cdc28p signal was plotted against the percentage of input lysate from
the mih1D hsl7-OFF strain.
(C–E) The indicated cyclin/Cdc28p complexes were isolated from the following strains harvested during exponential growth: (C) WT (DLY7646,
DLY7647, DLY7598, DLY7648, DLY7599, DLY7662); (D) hsl1D (DLY7735, DLY7718, DLY7873 DLY7770, DLY7749); (E) mih1D (DLY7857,
DLY7717, DLY7854, DLY7858, DLY7860, DLY7786). The ratio of pY19-to-total Cdc28p was quantitated for both the purified complexes and the
complete cellular pool of Cdc28p in lysates for each experiment. To account for gel-to-gel variability, the results from individual experiments
were normalized by dividing the ratio for each purified complex by the average ratio obtained from lysates used in that experiment. The average
normalized ratios for each cyclin/Cdc28p complex are displayed in arbitrary units as mean 6 SEM (n = 3) (pY19, red; PSTAIRE, green).Y19-phosphorylated and -unphosphorylated Clb5p/
Cdc28p and Clb2p/Cdc28p. We initially assumed that
stoichiometric phosphorylation would best be achieved
by overexpression of Swe1p, but we found that such
overexpression resulted in an aberrant failure to phos-
phorylate Clb2p/Cdc28p (Figure S3 and Supplemental
Results and Discussion). To induce a cell-cycle arrest
mediated by endogenous Swe1p, we generated strains
lacking Mih1p and expressing Hsl7p (which acts to-
gether with Hsl1p to promote Swe1p degradation [23])
from the regulatable GAL1 promoter. Upon transfer to
dextrose medium (mih1D hsl7-OFF), Hsl7p expression
is shut off, the protein is depleted, and the cells arrest
with elongated buds (because of the inability of Clb1,2p/
Cdc28p to trigger the apical-to-isotropic growth switch
[26]). Under these conditions, Clb2p and Clb5p com-
plexes are highly phosphorylated (Figure 4A; >80% by
2D gel analysis, Figure S3D). We treated complexes
purified from arrested cells with recombinant human
Cdc25 to dephosphorylate Y19. Histone H1 kinase
activities were then determined for equal amounts of
phosphorylated (mock treated) and dephosphorylatedCURBIO 5(hCdc25-treated) Clb5p and Clb2p complexes. Y19 de-
phosphorylation clearly stimulated both Clb2p/Cdc28p
and Clb5p/Cdc28p histone H1 kinase activity
(Figure 4B). Based on the degree of stimulation, Y19
phosphorylation had a greater than 6-fold inhibitory ef-
fect on Clb2p/Cdc28p. Western blotting confirmed that
hCdc25 treatment promoted efficient Cdc28p Y19
dephosphorylation without affecting the total amount
of Cdc28p present (Figure 4A). In addition, control ex-
periments showed that hCdc25 treatment had no effect
on unphosphorylated Cdc28p complexes from swe1D
cells, so any effects can be ascribed to Y19 dephos-
phorylation (unpublished results). Thus, Y19 phosphory-
lation clearly inhibits Clb5p/Cdc28p as well as Clb2p/
Cdc28p kinase activity in budding yeast.
The CKI Sic1p Protects Clb5p/Cdc28p Complexes
from Y19 Phosphorylation
If Clb5p/Cdc28p complexes can become phosphory-
lated at high stoichiometry inmih1D cells, and this phos-
phorylation inhibits their kinase activity, then how is it
that they can still promote timely DNA replication? One706
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1185Figure 3. LAT Does Not Affect DNA Replication even in the Absence of Mih1p
Cells were synchronized as in Figure 1.
(A) Budding and nuclear division in clb6D (DLY8245, open circle), clb6D swe1D (DLY8261, closed triangle), and clb6Dmih1D (DLY8441, closed
square) cells were monitored by fluorescence microscopy (n > 200).
(B) DNA replication was monitored by flow cytometry.
(C) FACS profiles for untreated (black) and LAT-treated (red) clb6D mih1D cells 30 min and 40 min after release from G1 arrest.possibility is that Clb5p/Cdc28p action is more rapid
than Clb5p/Cdc28p inhibition by Swe1p, providing
a window of opportunity for DNA replication before
Clb5p complexes are inactivated. Slow inhibition by
Swe1p could be due to intrinsically slow phosphoryla-
tion of Clb5p/Cdc28p (see below) and/or to initial
protection of Clb5p/Cdc28p from Swe1p by the CKI
Sic1p [13]. The sudden, switch-like degradation of
Sic1p at G1/S [27, 28] could then unleash a stockpile
of unphosphorylated Clb5p/Cdc28p.
To test whether Sic1p can protect Clb5p/Cdc28p
complexes from Y19 phosphorylation, we examined
the phosphorylation state of Clb5p-associated Cdc28p
inmih1D cells that were released from pheromone arrest
in the presence or absence of a stabilized form of Sic1p
(Sic1D4p) [27]. As shown in Figure 5B, Clb5p-associated
Cdc28p remained completely unphosphorylated when
stabilized Sic1p was present, suggesting that Sic1p
degradation must normally precede Swe1p-mediated
Clb5p/Cdc28p phosphorylation.
In principle, the protection conferred by Sic1p could
be direct (Sic1p binding occludes Y19 so that Swe1p
cannot phosphorylate it) or indirect (stabilized Sic1p
somehow leads to Swe1p inactivation). We have not
been able to generate highly active Swe1p for in vitro
studies to test the direct protection model. However,
Sic1p is functionally analogous to the p21/p27 family
of mammalian CKIs and is thought to share a similarCURBIOstructure in the CDK inhibitory domain [29]. Structural
considerations suggest that p27Kip1 binding would pre-
vent access of Wee1 to the target CDK tyrosine residue
[30]. Indeed, the addition of p27Kip1 completely inhibited
all observable phosphorylation of Cdk2 by Wee1 in vitro
(Figure 5C). Taken together, these findings suggest that
CKI binding directly protects the bound cyclin/CDK
complex from phosphorylation by Wee1 in both yeast
and animal cells.
Swe1p Phosphorylates Clb2p and Clb5p Complexes
at Different Rates In Vivo
Slow phosphorylation of Clb5p/Cdc28p by Swe1p after
Sic1p degradation may contribute to a ‘‘window of
opportunity.’’ To assess how rapidly Clb5p/Cdc28p
becomes phosphorylated after Sic1p degradation, we
devised an in vivo kinase assay. The assay involves
monitoring the phosphorylation of Clb5p/Cdc28p (and
for comparison, Clb2p/Cdc28p) after activation of a con-
ditional Swe1p in cells lacking Mih1p. Although the
absolute rate of phosphorylation is influenced by the ki-
netics of activation of the conditional Swe1p, this assay
has the advantage over standard in vitro assays be-
cause the kinase, substrate, and ATP concentrations
are all physiological and the reaction occurs in its natural
milieu.
To isolate a conditional allele ofSWE1, we screened for
swe1 mutants that would arrest the cell cycle of hsl1D5706
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1186Figure 4. Tyrosine Phosphorylation Inhibits
Both Clb5p- and Clb2p-Associated Kinase
Activity
(A) mih1D GAL1-HSL7 cells (DLY8197 and
DLY8199) were grown in dextrose-containing
medium for 22 hr to deplete Hsl7p (mih1D
hsl7-OFF). Clb2p/Cdc28p and Clb5p/
Cdc28p complexes were isolated and treated
with or without recombinant hCdc25, and the
ratio of pY19-to-total Cdc28p was assessed.
(B) Phosphorylated (mock-treated, open
square) and dephosphorylated (hCDC25-
treated, closed square) Cdc28p complexes
were assayed for their ability to phosphory-
late histone H1 in vitro. The amount of 32P
incorporation was normalized to the amount
of Cdc28p present in the reaction and is plot-
ted in arbitrary units (mean of two replicates).mih1D cells at 24C but not 37C (see Supplemental
Experimental Procedures). We isolated swe1-12, which
contains a single-point mutation changing E792 to Q.
Cells harboring this allele and lacking both Hsl1p and
Mih1p proliferate well at 37C (when Swe1-12p is inac-
tive) but arrest upon shift to 24C (Figure 6A). In this con-
text, there is very little Y19 phosphorylation at 37C, and
activation of Swe1-12p after shift-down leads to a pro-
gressive increase in Cdc28p phosphorylation (Figure 6B).
By isolating Clb2p-TAP or Clb5p-TAP complexes from
hsl1D mih1D swe1-12 cells, the rate of phosphorylation
of the associated Cdc28p after shift-down could be as-
sessed. To ensure that Swe1p, Clb5p, and Clb2p levels
were all high and that Sic1p was absent, we arrested
the cells in S phase by using hydroxyurea (HU) prior to
temperature shift. As shown in Figure 6C, Clb5p com-
plexes were phosphorylated much more slowly than
Clb2p complexes after shift to 24C. Thus, slow
phosphorylation may combine with the initial Sic1p-
mediated protection of Clb5p/Cdc28p complexes to al-
low DNA replication even inmih1D cells treated with LAT.
Discussion
Yeast cells live in a fluctuating environment in which
temperature, osmolarity, nutrients, and toxins can
change rapidly as a result of the day/night cycle, weather
patterns, and other organisms. Many such changes
provoke a transient stress response that depolarizes
the actin cytoskeleton, halts bud growth, and engages
the morphogenesis checkpoint [4]. Under these circum-
stances, it is clearly advantageous to delay nuclear
division until the bud is ready to receive a daughter nu-
cleus. In contrast, there is no evident benefit in delaying
DNA replication once cells have committed to enter the
cell cycle; indeed, lengthening S phase might render
cells vulnerable to DNA-damaging agents. Consistent
with these suppositions, the morphogenesis checkpoint
delays nuclear division without affecting S phase ([12,
32] and this work).CURBIO 5Specificity in the Function and Phosphorylation
of Different B Cyclin/Cdc28p Complexes
By deleting different cyclins and subjecting cells to actin
stress, we found that, unlike in lab-grown cells where
Clb1–6p have overlapping roles [17–20], in actin-
stressed cells, only Clb5,6p promote DNA replication
and only Clb3,4p promote spindle assembly. Thus,
Clb3–6p retain their biological function in stressed con-
ditions, presumably because of protection of the associ-
ated Cdc28p from tyrosine phosphorylation. Indeed, in
hsl1D cells, which mimic partial activation of the check-
point, only a low level of inhibitory phosphorylation was
observed on Clb3–6p/Cdc28p. By using mih1D and
swe1-Ts mutant strains and assaying phosphorylation
stoichiometry on different Cdc28p complexes in vivo,
we found that the low phosphorylation of Clb5p/
Cdc28p relative to Clb2p/Cdc28p involved both reduced
Swe1p-mediated phosphorylation and enhanced
Mih1p-mediated dephosphorylation of Clb5p/Cdc28p
complexes.
The differences in the extent of phosphorylation we
detected could arise from intrinsic biochemical prefer-
ences on the part of Swe1p and Mih1p for different
cyclin/Cdc28p complexes, the presence of binding
proteins that affect access of Swe1p/Mih1p to specific
substrates, and/or the degree to which Swe1p/Mih1p
and substrate complexes are coexpressed in time and
space. The latter hypothesis appears unlikely to account
for our results. First, Swe1p and Clb5p both accumulate
in late G1/S phase, whereas Clb2p accumulates in G2/M
and Mih1p is present constitutively ([13], unpublished
results). This expression pattern would favor phosphor-
ylation of Clb5p/Cdc28p rather than Clb2p/Cdc28p.
Second, Swe1p, Clb5p, and Clb2p are all concentrated
in the nucleus [33–35], whereas Mih1p is predominantly
cytoplasmic for most of the cell cycle (except late ana-
phase [unpublished results]). Swe1p and Clb2p are
also localized at the mother-bud neck [33, 35, 36].
Thus, Mih1p would have greater access to Clb2p/
Cdc28p than Clb5p/Cdc28p, yet we observed that706
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lated despite the reduced access. These considerations
imply that substrate preference and/or other regulators
account for the specificities we have documented.
One regulator that we identified as influencing Cdc28p
tyrosinephosphorylation is the CKI Sic1p. Sic1p can bind
to various Clb/Cdc28p complexes in vitro [37], but in vivo
it binds primarily to Clb5p and Clb6p complexes, be-
cause it is degraded before the other B cyclins accumu-
late [38]. We found that stabilized Sic1p protected Clb5p/
Cdc28p from Swe1p-mediated phosphorylation in vivo.
The structural basis for inhibition of Clb5p/Cdc28p by
Sic1p is thought to be similar to that of the mammalian
CKI p27Kip1 [29], whose crystal structure has been solved
in complex with Cyclin A/Cdk2 [30]. In this structure,
p27Kip1 exists in an extended conformation and makes
multiple interactions with both the kinase and cyclin sub-
units. The region surrounding the site of phosphorylation
(Tyr15 of Cdk2) by Wee1 is particularly distorted com-
pared to the free Cyclin A/Cdk2 complex. We found
that stoichiometric amounts of p27Kip1 completely abro-
gated the ability of Wee1 to phosphorylate Cyclin A/Cdk2
in vitro. This suggests that CKI binding protects cyclin/
Figure 5. CKIs Protect Bound CDK from Tyrosine Phosphorylation
(A) Representative DIC images of mih1D (DLY8700) and GAL1-
SIC1D4p mih1D (DLY8701) cells grown in YEPS (SUC) and induced
to express Sic1p by addition of galactose for 5 hr (GAL).
(B) Cells from the same strains were grown in YEPS and arrested in
G1 with pheromone. Sic1pD4p expression was induced with galac-
tose 30 min prior to release from the G1 arrest and maintained after
release into YEPG. Cdc28p Y19 phosphorylation was assessed for
Clb5p/Cdc28p complexes isolated from cells collected 75 min after
release when the majority of the cells had budded.
(C) Purified Cyclin A/Cdk2 was incubated with GST-Wee1 and
[g-32P]ATP in the presence or absence of p27Kip1 as described in
the Supplemental Experimental Procedures. Phosphorylated Cdk2
was visualized with a phosphoimager.CURBIOCDK complexes from inhibitory phosphorylation by per-
turbing the recognition site for the inhibitory kinases, in
both yeast and mammalian cells.
Figure 6. Swe1p Phosphorylates Clb2p/Cdc28p More Rapidly than
Clb5p/Cdc28p
(A) swe1-12 hsl1D mih1D cells containing Clb2p-TAP (DLY8726) or
Clb5p-TAP (DLY8727) were grown at 37C and shifted to 24C for
5 hr and processed for DIC imaging.
(B) Cells from those strains were grown in 0.5 M HU at 37C for 5 hr
and shifted to 24C in the continued presence of HU (>90% large-
budded arrest). Cdc28p phosphorylation was assessed by western
blot analysis of TCA-precipitated total cellular protein.
(C) Clb2p and Clb5p complexes were isolated from cells in (B) at the
indicated times after shift to 24C, and Cdc28p Y19 phosphorylation
was assessed.
(D) The ratio of pY19-to-total Cdc28p was determined for the
purified Cdc28p complexes shown in (C).5706
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in the regulation of individual B cyclin/CDK complexes
that can explain why the cell-cycle arrest by the morpho-
genesis checkpoint affects nuclear division but not DNA
replication. Clb5p is synthesized in late G1 and associ-
ates with abundant free Cdc28p and Sic1p [13]. Sic1p
protects this complex from Swe1p until the Sic1p is
degraded at G1/S. Clb5p/Cdc28p complexes are now
susceptible to phosphorylation by Swe1p but are rapidly
dephosphorylated by Mih1p so that net phosphorylation
remains low. In the absence of Mih1p (or if Mih1p is
inhibited by the checkpoint), Clb5p/Cdc28p becomes
heavily phosphorylated, but this takes a considerable
amount of time, leaving a window between Sic1p degra-
dation and inhibitory phosphorylation that suffices to
allow Clb5p/Cdc28p to trigger DNA replication. In con-
trast to Clb5p, Clb2p is synthesized in late S/G2 when
Sic1p is absent and is phosphorylated by Swe1p more
rapidly than is Clb5p/Cdc28p. Thus, in stressful condi-
tions that trigger the morphogenesis checkpoint,
Clb2p/Cdc28p complexes are rapidly inhibited, thereby
preventing nuclear division.
To What Degree Does Tyrosine Phosphorylation
Inhibit B Cyclin/CDK Activity?
In the model yeasts S. cerevisiae and Schizosaccharo-
myces pombe, both DNA replication and mitosis are
triggered by members of the B cyclin family in complex
with a single CDK: S. pombe has three such cyclins and
S. cerevisiae has six [13, 39]. In both yeasts, a single B
cyclin can drive both S and M phase in appropriately en-
gineered mutants [40, 41], which raises the question of
why these events don’t happen simultaneously. An ap-
pealing answer, suggested by Stern and Nurse, is that
although low levels of B cyclin/CDK activity suffice to
trigger S phase, higher levels are required to trigger mi-
tosis [42]. In S. pombe, mitosis is restrained by Wee1-
mediated inhibitory phosphorylation of B cyclin/CDK
complexes, but residual kinase activity can be detected
and suffices to trigger DNA replication. It is unclear
whether the residual activity in that case is intrinsic to ty-
rosine-phosphorylated cyclin/CDK complexes or is due
to a subpopulation of unphosphorylated complexes.
The phospho-mimetic allele cdc28-Y19E retains de-
tectable kinase activity in vitro and can support DNA
replication in S. cerevisiae [16], suggesting that even
fully phosphorylated Cdc28p could initiate DNA replica-
tion, with the important caveat that the Y19E mutation
may not accurately mimic phosphorylated Cdc28p. In
our experiments, we found that under conditions that
promote Swe1p-mediated Cdc28p phosphorylation,
Clb1,2p/Cdc28p no longer promoted S phase, spindle
assembly, or nuclear division. Consistent with this re-
sult, Aparicio and colleagues reported that DNA replica-
tion driven by a prematurely expressed Clb2p (instead of
the normal Clb5p) was delayed by Swe1p [31]. Thus, it
would appear that at least Clb1,2p complexes do not re-
tain a biologically relevant kinase activity in the phos-
phorylated state.
We found that, like Clb2p/Cdc28p, Clb5p/Cdc28p
in vitro kinase activity was inhibited by Y19 phosphory-
lation. Given the diversity of cyclin/CDK complexes that
are clearly inhibited by tyrosine phosphorylation in
metazoans and structural considerations, suggestingCURBIO 5that phosphorylation acts by reducing ATP binding
and/or catalysis [43, 44], it seems likely that tyrosine
phosphorylation universally inhibits CDK activity.
Conclusions
A number of studies have suggested that the various B
cyclins in S. cerevisiae differ both in the effectiveness
with which they promote particular events and in the
manner in which they are regulated [45–49], providing
an opportunity to fine-tune the cell cycle under different
conditions. Our findings demonstrate that differences in
the regulation of specific B cyclin/Cdc28p complexes by
Swe1p and Mih1p tailor the cell-cycle response of yeast
cells to actin stress, permitting DNA replication and
spindle assembly while blocking nuclear division.
In contrast to yeasts, metazoans employ different
classes of cyclin acting with different CDKs to promote
S phase and mitosis. Moreover, metazoans are known
to employ Wee1-mediated CDK phosphorylation to
delay DNA replication as well as mitosis [3], suggesting
that there is less target specificity on the part of meta-
zoan Wee1/Cdc25 than that exhibited by yeast Swe1p/
Mih1p. These differences raise interesting questions
regarding the evolution of cell-cycle regulators: when
was specificity in the action of Wee1/Cdc25 acquired
(or lost) during evolution? Why did different classes of
cyclins evolve? Did changes in cyclin functional special-
ization coevolve with changes in their regulation by
tyrosine phosphorylation? Further investigation of these
issues should shed light on the evolution of cell-cycle
control strategies.
Supplemental Data
Three figures, one table, Results and Discussion, and Experimental
Procedures are available at http://www.current-biology.com/cgi/
content/full/17/14/1181/DC1/.
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